Humacyte, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUMA research report →
About the company
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields.
- CEO
- Laura E. Niklason
- IPO
- 2020
- Employees
- 218
- HQ
- Durham, NC, US
Price Chart
- Market Cap
- $119.28M
- P/E
- -1.21
- P/S
- 59.17
- P/B
- 12.08
- EV/EBITDA
- -1.71
- Div Yield
- 0.00%
- Gross Margin
- -748.51%
- Op Margin
- -5649.21%
- Net Margin
- -4840.82%
- ROE
- -2781.56%
- ROIC
- -117.66%
- Revenue
- $2.04M · 0.00%
- Net Income
- $-40,833,000 · 72.54%
- EPS
- $-0.26 · 79.37%
- Op Income
- $-107,437,000
- FCF YoY
- -6.25%
- 52W High
- $2.84
- 52W Low
- $0.55
- 50D MA
- $0.99
- 200D MA
- $1.16
- Beta
- 2.46
- Avg Volume
- 9.99M
Get TickerSpark's AI analysis on HUMA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Windham-Bannister Susan Richards | other | 80,000 |
| Jun 11, 26 | Constantino Michael T. | other | 80,000 |
| Jun 11, 26 | Wallace Max N. | other | 80,000 |
| Jun 11, 26 | Niklason Laura E | other | 80,000 |
| Jun 11, 26 | Sebelius Kathleen | other | 80,000 |
| Jun 11, 26 | Jones Keith Anthony | other | 80,000 |
| Jun 11, 26 | Green Charles Bruce | other | 80,000 |
| Jun 11, 26 | Seimetz Diane | other | 80,000 |
| Jun 11, 26 | Bamforth John Philip | other | 80,000 |
| Jun 11, 26 | Brown Emery N. | other | 80,000 |
Our HUMA coverage
Recent articles, reports, and earnings notes.
No research on HUMA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HUMA report →Similar companies
Peers in the same neighborhood.